vs
Side-by-side financial comparison of GERON CORP (GERN) and Namib Minerals (NAMM). Click either name above to swap in a different company.
GERON CORP is the larger business by last-quarter revenue ($47.2M vs $41.9M, roughly 1.1× Namib Minerals).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Namib Minerals is a Namibia-based natural resources firm focused on exploration, development and extraction of high-demand mineral deposits including uranium, copper and lithium. It operates across licensed southern African sites, supplying raw materials to global clean energy, construction and electronics manufacturing sectors.
GERN vs NAMM — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $41.9M |
| Net Profit | $-18.4M | — |
| Gross Margin | — | 45.7% |
| Operating Margin | -29.4% | 29.8% |
| Net Margin | -39.0% | — |
| Revenue YoY | 67.1% | — |
| Net Profit YoY | 30.3% | — |
| EPS (diluted) | $-0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $47.2M | — | ||
| Q2 25 | $49.0M | $41.9M | ||
| Q1 25 | $39.6M | — | ||
| Q3 24 | $28.3M | — | ||
| Q2 24 | $882.0K | — | ||
| Q1 24 | $304.0K | — | ||
| Q4 23 | $23.0K | — | ||
| Q3 23 | $164.0K | — |
| Q3 25 | $-18.4M | — | ||
| Q2 25 | $-16.4M | — | ||
| Q1 25 | $-19.8M | — | ||
| Q3 24 | $-26.4M | — | ||
| Q2 24 | $-67.4M | — | ||
| Q1 24 | $-55.4M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-44.8M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | 45.7% | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q3 25 | -29.4% | — | ||
| Q2 25 | -25.4% | 29.8% | ||
| Q1 25 | -42.2% | — | ||
| Q3 24 | -99.8% | — | ||
| Q2 24 | -7860.9% | — | ||
| Q1 24 | -18465.1% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -29031.7% | — |
| Q3 25 | -39.0% | — | ||
| Q2 25 | -33.4% | — | ||
| Q1 25 | -50.1% | — | ||
| Q3 24 | -93.5% | — | ||
| Q2 24 | -7639.8% | — | ||
| Q1 24 | -18220.4% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -27320.1% | — |
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.02 | — | ||
| Q1 25 | $-0.03 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.10 | — | ||
| Q1 24 | $-0.09 | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $248.7M | — |
| Total Assets | $567.4M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $78.1M | — | ||
| Q2 25 | $77.7M | — | ||
| Q1 25 | $83.7M | — | ||
| Q3 24 | $60.3M | — | ||
| Q2 24 | $116.9M | — | ||
| Q1 24 | $189.8M | — | ||
| Q4 23 | $70.0M | — | ||
| Q3 23 | $30.7M | — |
| Q3 25 | $248.7M | — | ||
| Q2 25 | $259.5M | — | ||
| Q1 25 | $268.2M | — | ||
| Q3 24 | $292.3M | — | ||
| Q2 24 | $306.7M | — | ||
| Q1 24 | $344.9M | — | ||
| Q4 23 | $247.9M | — | ||
| Q3 23 | $290.6M | — |
| Q3 25 | $567.4M | — | ||
| Q2 25 | $555.2M | — | ||
| Q1 25 | $562.5M | — | ||
| Q3 24 | $444.9M | — | ||
| Q2 24 | $449.4M | — | ||
| Q1 24 | $482.1M | — | ||
| Q4 23 | $394.1M | — | ||
| Q3 23 | $413.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | $11.4M |
| Free Cash FlowOCF − Capex | — | $7.4M |
| FCF MarginFCF / Revenue | — | 17.6% |
| Capex IntensityCapex / Revenue | — | 9.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-13.6M | — | ||
| Q2 25 | $-27.4M | $11.4M | ||
| Q1 25 | $-48.0M | — | ||
| Q3 24 | $-58.9M | — | ||
| Q2 24 | $-53.5M | — | ||
| Q1 24 | $-62.3M | — | ||
| Q4 23 | $-167.7M | — | ||
| Q3 23 | $-50.8M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | $7.4M | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-53.7M | — | ||
| Q1 24 | $-62.9M | — | ||
| Q4 23 | $-168.6M | — | ||
| Q3 23 | $-51.0M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | 17.6% | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6086.6% | — | ||
| Q1 24 | -20680.3% | — | ||
| Q4 23 | -732926.1% | — | ||
| Q3 23 | -31116.5% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | 9.6% | ||
| Q1 25 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 23.4% | — | ||
| Q1 24 | 202.3% | — | ||
| Q4 23 | 3608.7% | — | ||
| Q3 23 | 117.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
